Tenapanor (Butylene-d8)

Tenapanor (Butylene-d8) is listed under Metabolite and is intended for analytical research, quality control and pharmaceutical reference standard applications. It is associated with Tenapanor. The product is supplied by Clearsynth under CAT No. CS-T-97605. Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight and product enquiry details.

Product Specifications

Overview

"17-[[[3-[ (4S) -6,8-Dichloro-1,2,3,4-tetrahydro-2-methyl-4-isoquinolinyl]phenyl]sulfonyl]amino]-N-[2-[2-[2-[[[3-[ (4S) -6,8-dichloro-1,2,3,4-tetrahydro-2-methyl-4-isoquinolinyl]phenyl]sulfonyl]amino]ethoxy]ethoxy]ethyl]-8-oxo-12,15-dioxa-2,7,9-triazaheptadecanamide-d8 (deuterium labeled) is an inhibitor of sodium/hydrogen exchanger isoform 3 (NHE3), which is a major absorptive sodium transporter. It has therapeutic potential for lowering gastrointestinal sodium absorption and improving fluid overload-related symptoms, such as hypertension and proteinuria, in patients with CKD."

Synonyms

Tenapanor (Butylene-d8)

Molecular Formula

C 50 H 58 D 8 Cl 4 N 8 O 10 S 2

Molecular Weight

1153.1

Additionnal Information

Tenapanor (Butylene-d8) is supplied with detailed characterization data compliant with regulatory guideline. Tenapanor (Butylene-d8) can be used for analytical method development, method validation (AMV), Quality Control (QC) application for Abbreviated New Drug Application (ANDA), or during commercial production of Tenapanor.